Grants per year
Search results
-
Active
Prot #RVT-2301-201: A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease
Mylvaganam, R. J. (PD/PI)
Ice Global Consulting, Inc., Pulmovant, Inc.
11/7/24 → 11/7/27
Project: Research project
-
Prot #GB002-3101: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)
Mylvaganam, R. J. (PD/PI)
PPD Investigator Services, LLC, GB002, Inc.
3/12/24 → 3/12/27
Project: Research project
-
Prot #REM-PH-418: A Phase 4, Prospective, Multicenter, Single-Arm, Study of a Mean Pulmonary Artery Pressure-Targeted Approach with Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patients with Pulmonary Arterial Hypertensi
Mylvaganam, R. J. (PD/PI)
2/23/23 → 2/23/26
Project: Research project
-
Classification and Prognostication in Pulmonary Thromboembolism Using Computed Tomography Image Analytics
Cuttica, M. J. (PD/PI), Cuttica, M. J. (PD/PI), Mylvaganam, R. J. (Co-Investigator) & Mylvaganam, R. J. (Co-Investigator)
Brigham and Women’s Hospital, National Heart, Lung, and Blood Institute
9/1/22 → 6/30/27
Project: Research project
-
Finished
Exploring the Role of T-cell Associated Pulmonary Vasculature Injury and Right Ventricular Dysfunction
Cuttica, M. J. (PD/PI), Budinger, G. S. (Other), Kalhan, R. (Other) & Mylvaganam, R. J. (Other)
Actelion Pharmaceuticals US, Inc.
10/1/21 → 9/30/22
Project: Research project